跳至主要内容
临床试验/NCT04447443
NCT04447443撤回不适用

Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家开始时间: 2020年6月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Therapeutic effect on the chemotherapy-related grade 2 to 4 diarrhea

研究概览

简要总结

This study evaluates longitudinal data associating changes in gut microbiota composition and diversity, defecation, performance status and adverse reactions in response to prebiotic fiber supplementation in patients with gastrointestinal cancer chemotherapy-related diarrhea. 120 adult participants , age 18 to 65 years, will be randomized into one of the two arms. Arm A (intervention group) will receive prebiotic fiber and loperamide hydrochloride capsule(a drug for standard treatment). Arm B will receive maltodextrin placebo and loperamide hydrochloride capsule.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18-65, be able to comply with the protocol
  • •Life expectancy greater than 3 months
  • •Patients with cytologically or histologically confirmed diagnosis of gastrointestinal cancers
  • •Undergoing chemotherapy, not synchronized with radiotherapy and other anti-tumor treatments
  • •Chemotherapy-related diarrhea grade 2-4
  • •Not experience diarrhea before chemotherapy

排除标准

  • •age<18 or >65
  • •Patients who cannot eat by mouth for example chewing disorders, difficulty swallowing, intractable vomiting, gastrointestinal obstruction or gastrointestinal tract bleeding
  • •Other acute or chronic diarrhea or colostomy
  • •Patients with other severe adverse effects of chemotherapy other than diarrhea
  • •Patients with severe diseases of heart, kidney, liver and other major organs
  • •Use of any other drug for promoting intestine movement
  • •Use of any other drug or dietary supplement for chemotherapy-related diarrhea such as other fiber supplements, probiotics, octreotide
  • •Allergic to the components of the intervention dietary supplements;
  • •Pregnancy (positive serum pregnancy test) and lactation
  • •Any other serious or uncontrolled illness which the investigator think is undesirable for the patient to enter the trial

研究组 & 干预措施

Maltodextrin

Placebo Comparator

干预措施: Maltodextrin + loperamide hydrochloride capsule (Dietary Supplement)

Prebiotic Fiber

Experimental

干预措施: Prebiotic Fiber Supplement + loperamide hydrochloride capsule (Dietary Supplement)

结局指标

主要结局

Therapeutic effect on the chemotherapy-related grade 2 to 4 diarrhea

时间窗: 2 weeks

Numbers of bowel movements per day

次要结局

  • Changs in Karnofsky Performance Status(2 weeks)
  • onset time(2 weeks)
  • Gut microbiota changes in response to intervention(Change from baseline in gut microbiota at 1 and 2 weeks ])
  • Adverse events(2 weeks)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Impact of Dietary Fiber as Prebiotics on... | 临床试验